Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 3

Plasma and salivary irisin levels in lepramatous leprosy patients

Pages
814–818
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to clarifythe role and prognostic value of the irisin in leprosy with a large number of patients examined before and after the treatments.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to investigate the plasma and salivary irisin levels in leprosy patients, as well as to evaluate the role of the irisin inthe leprosy pathogenesis.
📊
Key Findings & Data:Irisin, a novel protein, has been associated with several inflammatory diseases and demonstrated in the peripheral nervecells, deep sebaceous glands, and saliva excessively.
💡
Conclusion & Impact:Further studies are needed to clarifythe role and prognostic value of the irisin in leprosy with a large number of patients examined before and after the treatments.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to investigate the plasma and salivary irisin levels in leprosy patients, as well as to evaluate the role of the irisin inthe leprosy pathogenesis. Leprosy is a granulomatous disease with the peripheral nerves, mucous membrane, and skin involvementprimarily. Irisin, a novel protein, has been associated with several inflammatory diseases and demonstrated in the peripheral nervecells, deep sebaceous glands, and saliva excessively. To our knowledge, there is no study investigating the irisin levels in patientswith leprosy.Material and Methods: We conducted a case-control study on 20 patients with lepromatous leprosy and 20 healthy controls betweenJanuary 2016 and January 2017. Of the participants, the demographic data and disease history including duration of the disease,any current treatments, and presence of any other family members with leprosy were recorded. The plasma and salivary irisin levelsof the participants were measured by enzyme-linked immunosorbent assay (ELISA). Additionally, the serum levels of C-reactiveprotein (CRP), glucose, hemoglobin A1c (HbA1C), triglyceride, cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein(LDL) were evaluated in both groups.Results: The plasma and salivary irisin levels were significantly lower in the patient group than those in the control group (P = 0.001and P = 0.03, respectively). In patients with leprosy, the serum and salivary irisin levels had a positive correlation (r: 576, p: 0.008). Inaddition, there was a negative correlation between the plasma irisin and CRP levels (r: −468, p: 0.037).Conclusion: The irisin may act an immunomodulatory role in leprosy. The irisin production is probably suppressed by the increasedinflammatory markers in leprosy or the bacillus to reach the temperature for its reproduction. Further studies are needed to clarifythe role and prognostic value of the irisin in leprosy with a large number of patients examined before and after the treatments.

🔖

Cite This Article

KALAYCI, M., ALATAS, E. T., POLAT, A. K., DOGAN, G., BELLI, A. A. (2022). Plasma and salivary irisin levels in lepramatous leprosy patients. Annals of Medical Research, Cilt: 27 - Sayı: 3, 814–818. https://ajindex.com/articles/446208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Pereira RM, Calegari-Silva TC, Hernandez MO, et al. Mycobacterium leprae induces NF-kappaB-dependent transcription repression in human Schwann cells. Biochem Biophys Res Commun 2005;335:20-6
  2. Lockwood DNJ. Leprosy. In: Burns DA, Breatnach SM, Cox N, Griffits CE, et al, editors. Rook’s text book of dermatology. 7th edition. Oxford: Blackwell Publishing 2004;1-21
  3. Rea TH, Modlin RL. Leprosy. In: Wolf K, Goldsmith LA, Karz S, Gilchrest BA, Paller AS, Leffell DJ, et al, editors. Dermatology in General Medicine. 7th edition. New York: McGraw Hill Professional 2008;1786-96
  4. Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1- alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463-8
  5. Norheim F, Langleite TM, Hjorth M, et al. The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 2014;281:739-49
  6. Alatas ET, Kalayci M, Kara A, et al. Association between insülin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris. Dermatologica Sinica 2017;35:12-5
  7. Hojlund K, Boström P. Irisin in obesity and type 2 diabetes. J Diabetes Complications 2013;27:303-4
  8. Gagnini M, Cabiati M, Del Turco S, et al. Increased FNDC5/Irisin expression in human hepatocellular carcinoma. Peptides 2017;88;62-6
  9. Aydin S, Kuloglu T, Aydin S, et al. Cardiac and skeletal muscle serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides 2014;52:68-73
  10. Aydin S, Aydin S, Kobat MA, et al. Decreased saliva/ serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology. Peptides 2014:56;141-5
  11. Ramos-e-Silva M, Ribeiro de Castro MC. Dermatology. In: Bolognia JL, Jorizzo JL, Rapini RP, et al, editors. Leprosy. 3rd edition. Philadelphia: Elsevier Saunders 2012;1221-42
  12. Lopez-Legarrea P, de la Iglesia R, Crujeiras AB, et al. Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects. Nutr Diabetes 2014;4:110
  13. Shi X, Lin M, Liu C, et al. Elevated circulating irisin is associated with lower risk of insulin resistance: Association and path analyses of obese Chinese adults. BMC Endocr Disord 2016;16:44
  14. Chen JQ, Huang YY, Gusdon AM, et al. Irisin: a new molecular m